Research article
Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection
David M. Patrick, Mark W. Tyndall, Peter G.A. Cornelisse, Kathy Li, Chris H. Sherlock, Michael L. Rekart, Steffanie A. Strathdee, Sue L. Currie, Martin T. Schechter and Michael V. O'Shaughnessy
CMAJ October 02, 2001 165 (7) 889-895;
David M. Patrick
From the *University of British Columbia Centre for Disease Control, University of British Columbia, Vancouver, BC; †Department of Medicine, University of British Columbia, Vancouver, BC; ‡British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC; §Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC; ¶Fred Hutchinson Cancer Research Center, Seattle, WA; **Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC; ††Johns Hopkins School of Hygiene and Public Health, Baltimore, MD; and ‡‡University of California, San Francisco Centre for AIDS Prevention Studies, San Francisco, CA
Mark W. Tyndall
From the *University of British Columbia Centre for Disease Control, University of British Columbia, Vancouver, BC; †Department of Medicine, University of British Columbia, Vancouver, BC; ‡British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC; §Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC; ¶Fred Hutchinson Cancer Research Center, Seattle, WA; **Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC; ††Johns Hopkins School of Hygiene and Public Health, Baltimore, MD; and ‡‡University of California, San Francisco Centre for AIDS Prevention Studies, San Francisco, CA
Peter G.A. Cornelisse
From the *University of British Columbia Centre for Disease Control, University of British Columbia, Vancouver, BC; †Department of Medicine, University of British Columbia, Vancouver, BC; ‡British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC; §Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC; ¶Fred Hutchinson Cancer Research Center, Seattle, WA; **Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC; ††Johns Hopkins School of Hygiene and Public Health, Baltimore, MD; and ‡‡University of California, San Francisco Centre for AIDS Prevention Studies, San Francisco, CA
Kathy Li
From the *University of British Columbia Centre for Disease Control, University of British Columbia, Vancouver, BC; †Department of Medicine, University of British Columbia, Vancouver, BC; ‡British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC; §Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC; ¶Fred Hutchinson Cancer Research Center, Seattle, WA; **Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC; ††Johns Hopkins School of Hygiene and Public Health, Baltimore, MD; and ‡‡University of California, San Francisco Centre for AIDS Prevention Studies, San Francisco, CA
Chris H. Sherlock
From the *University of British Columbia Centre for Disease Control, University of British Columbia, Vancouver, BC; †Department of Medicine, University of British Columbia, Vancouver, BC; ‡British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC; §Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC; ¶Fred Hutchinson Cancer Research Center, Seattle, WA; **Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC; ††Johns Hopkins School of Hygiene and Public Health, Baltimore, MD; and ‡‡University of California, San Francisco Centre for AIDS Prevention Studies, San Francisco, CA
Michael L. Rekart
From the *University of British Columbia Centre for Disease Control, University of British Columbia, Vancouver, BC; †Department of Medicine, University of British Columbia, Vancouver, BC; ‡British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC; §Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC; ¶Fred Hutchinson Cancer Research Center, Seattle, WA; **Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC; ††Johns Hopkins School of Hygiene and Public Health, Baltimore, MD; and ‡‡University of California, San Francisco Centre for AIDS Prevention Studies, San Francisco, CA
Steffanie A. Strathdee
From the *University of British Columbia Centre for Disease Control, University of British Columbia, Vancouver, BC; †Department of Medicine, University of British Columbia, Vancouver, BC; ‡British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC; §Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC; ¶Fred Hutchinson Cancer Research Center, Seattle, WA; **Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC; ††Johns Hopkins School of Hygiene and Public Health, Baltimore, MD; and ‡‡University of California, San Francisco Centre for AIDS Prevention Studies, San Francisco, CA
Sue L. Currie
From the *University of British Columbia Centre for Disease Control, University of British Columbia, Vancouver, BC; †Department of Medicine, University of British Columbia, Vancouver, BC; ‡British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC; §Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC; ¶Fred Hutchinson Cancer Research Center, Seattle, WA; **Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC; ††Johns Hopkins School of Hygiene and Public Health, Baltimore, MD; and ‡‡University of California, San Francisco Centre for AIDS Prevention Studies, San Francisco, CA
Martin T. Schechter
From the *University of British Columbia Centre for Disease Control, University of British Columbia, Vancouver, BC; †Department of Medicine, University of British Columbia, Vancouver, BC; ‡British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC; §Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC; ¶Fred Hutchinson Cancer Research Center, Seattle, WA; **Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC; ††Johns Hopkins School of Hygiene and Public Health, Baltimore, MD; and ‡‡University of California, San Francisco Centre for AIDS Prevention Studies, San Francisco, CA
Michael V. O'Shaughnessy
From the *University of British Columbia Centre for Disease Control, University of British Columbia, Vancouver, BC; †Department of Medicine, University of British Columbia, Vancouver, BC; ‡British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC; §Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC; ¶Fred Hutchinson Cancer Research Center, Seattle, WA; **Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC; ††Johns Hopkins School of Hygiene and Public Health, Baltimore, MD; and ‡‡University of California, San Francisco Centre for AIDS Prevention Studies, San Francisco, CA
In this issue
CMAJ
Vol. 165, Issue 7
2 Oct 2001
Article tools
Respond to this article
Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection
David M. Patrick, Mark W. Tyndall, Peter G.A. Cornelisse, Kathy Li, Chris H. Sherlock, Michael L. Rekart, Steffanie A. Strathdee, Sue L. Currie, Martin T. Schechter, Michael V. O'Shaughnessy
CMAJ Oct 2001, 165 (7) 889-895;
Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection
David M. Patrick, Mark W. Tyndall, Peter G.A. Cornelisse, Kathy Li, Chris H. Sherlock, Michael L. Rekart, Steffanie A. Strathdee, Sue L. Currie, Martin T. Schechter, Michael V. O'Shaughnessy
CMAJ Oct 2001, 165 (7) 889-895;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Retention in care and mortality trends among patients receiving comprehensive care for HIV infection: a retrospective cohort study
- First Nations hepatitis C virus infections: Six-year retrospective study of on-reserve rates of newly reported infections in northwestern Ontario
- Misplaced advocacy: What does better hepatitis C treatment really mean?
- Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort
- Developing and validating a scoring tool for identifying people who inject drugs at increased risk of hepatitis C virus infection
- A study on HIV and hepatitis C virus among commercial sex workers in Tallinn
- Effect of serostatus for hepatitis C virus on mortality among antiretrovirally naive HIV-positive patients
- What's new for injection drug users with HIV infection?